Sex Differences in Safety and Effectiveness of LAAO: Insights From the Amulet IDE Trial.

Alkhouli, Mohamad; Russo, Andrea M; Thaler, David; Windecker, Stephan; Anderson, Jordan A; Gage, Ryan; Lakkireddy, Dhanunjaya (2022). Sex Differences in Safety and Effectiveness of LAAO: Insights From the Amulet IDE Trial. JACC. Cardiovascular Interventions, 15(21), pp. 2143-2155. Elsevier 10.1016/j.jcin.2022.06.037

[img] Text
1-s2.0-S1936879822013413-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB)

BACKGROUND

Women have higher rates of acute complications after left atrial appendage occlusion (LAAO). However, data on long-term safety and effectiveness are limited.

OBJECTIVES

The aim of this study was to examine sex-specific short- and long-term outcomes after LAAO in the Amulet IDE (Amplatzer™ Amulet™ LAA Occluder) trial.

METHODS

The following outcomes were compared between men and women: in-hospital complications, device-related outcomes (peridevice leak at 45 days and device-related thrombus at 18 months), and long-term clinical outcomes (death, thromboembolism, and bleeding). Subanalyses for the interaction between sex and device type were performed.

RESULTS

A total of 1,833 patients underwent attempted device implantation (917 with the Amulet and 916 with the Watchman), of whom 734 were women (40%). Device success was 97.4% in men and 97.1% in women (P = 0.60). Rates of major in-hospital adverse events were higher in women (4.4% vs 1.9%; P < 0.01), driven by major bleeding (3.7% vs 1.0%; P < 0.01) and pericardial effusion requiring intervention (2.0% vs 0.5%; P < 0.01). Peridevice leak and device-related thrombus were similar in men and women (18.3% vs 18.9% [P = 0.78] and 3.3% vs 5.0% [P = 0.10], respectively). There were no differences between men and women in rates of ischemic stroke or systemic embolism (2.6% vs 2.6%; P = 0.98), transient ischemic attack (1.3% vs 1.6%; P = 0.69), hemorrhagic stroke (0.5% vs 0.4%; P = 0.88), major bleeding (10.1% vs 10.9%; P = 0.49), cardiovascular death (4.3% vs 3.5%; P = 0.45), or all-cause death (8.9% vs 6.9%; P = 0.16).

CONCLUSIONS

In the Amulet IDE trial, long-term clinical outcomes including effectiveness following LAAO were comparable in men and women despite the higher rates of in-hospital complications due to major bleeding and pericardial effusion in women. (Amplatzer™ Amulet™ LAA Occluder Trial [Amulet IDE]; NCT02879448).

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1876-7605

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

15 Nov 2022 09:12

Last Modified:

05 Dec 2022 16:28

Publisher DOI:

10.1016/j.jcin.2022.06.037

PubMed ID:

36357018

Uncontrolled Keywords:

atrial fibrillation left atrial appendage occlusion sex differences stroke

BORIS DOI:

10.48350/174721

URI:

https://boris.unibe.ch/id/eprint/174721

Actions (login required)

Edit item Edit item
Provide Feedback